Differential efficacy of dengue vaccine by immune status.

Rodriguez-Barraquer, Isabel; Mier-Y-Teran-Romero, Luis; Ferguson, Neil; Burke, Donald S; Cummings, Derek A T

Rodriguez-Barraquer, Isabel; Mier-Y-Teran-Romero, Luis; Ferguson, Neil; Burke, Donald S; Cummings, Derek A T.

Afiliação

Rodriguez-Barraquer I; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: isabelr@jhu.edu.
Mier-Y-Teran-Romero L; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Ferguson N; Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK.
Burke DS; University of Pittsburgh Graduate School of Public Health.
Cummings DAT; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Lancet ; 385(9979): 1726, 2015 May 02.

Article em En | MEDLINE | ID: mdl-25943936

Assuntos

Vacinas contra Dengue/administração & dosagem; Dengue/prevenção & controle; Feminino; Humanos; Masculino

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dengue / Vacinas contra Dengue Limite: Female / Humans / Male Idioma: En Revista: Lancet Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google